File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors

TitleLong-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors
Authors
KeywordsSARS
glucocorticoids
follow-up
clinical outcomes
avascular necrosis
Issue Date2020
PublisherOxford University Press. The Journal's web site is located at http://www.oxfordjournals.org/our_journals/cid/
Citation
Clinical Infectious Diseases, 2020, Epub 2020-07-15 How to Cite?
AbstractUse of high-dose glucocorticoids for COVID-19 (caused by SARS-CoV-2) is controversial because of safety concerns. We examined the long-term consequences of glucocorticoid use in severe acute respiratory syndrome (caused by SARS-CoV-1) survivors. Results showed that high-dose glucocorticoids greatly increased the long-term risk of avascular necrosis but not other major diseases.
Persistent Identifierhttp://hdl.handle.net/10722/286247
ISSN
2019 Impact Factor: 8.313
2015 SCImago Journal Rankings: 4.742
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorSing, CW-
dc.contributor.authorTan, KCB-
dc.contributor.authorWong, ICK-
dc.contributor.authorCheung, BMY-
dc.contributor.authorCheung, CL-
dc.date.accessioned2020-08-31T07:01:15Z-
dc.date.available2020-08-31T07:01:15Z-
dc.date.issued2020-
dc.identifier.citationClinical Infectious Diseases, 2020, Epub 2020-07-15-
dc.identifier.issn1058-4838-
dc.identifier.urihttp://hdl.handle.net/10722/286247-
dc.description.abstractUse of high-dose glucocorticoids for COVID-19 (caused by SARS-CoV-2) is controversial because of safety concerns. We examined the long-term consequences of glucocorticoid use in severe acute respiratory syndrome (caused by SARS-CoV-1) survivors. Results showed that high-dose glucocorticoids greatly increased the long-term risk of avascular necrosis but not other major diseases.-
dc.languageeng-
dc.publisherOxford University Press. The Journal's web site is located at http://www.oxfordjournals.org/our_journals/cid/-
dc.relation.ispartofClinical Infectious Diseases-
dc.rightsPre-print: Journal Title] ©: [year] [owner as specified on the article] Published by Oxford University Press [on behalf of xxxxxx]. All rights reserved. Pre-print (Once an article is published, preprint notice should be amended to): This is an electronic version of an article published in [include the complete citation information for the final version of the Article as published in the print edition of the Journal.] Post-print: This is a pre-copy-editing, author-produced PDF of an article accepted for publication in [insert journal title] following peer review. The definitive publisher-authenticated version [insert complete citation information here] is available online at: xxxxxxx [insert URL that the author will receive upon publication here]. -
dc.subjectSARS-
dc.subjectglucocorticoids-
dc.subjectfollow-up-
dc.subjectclinical outcomes-
dc.subjectavascular necrosis-
dc.titleLong-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors-
dc.typeArticle-
dc.identifier.emailSing, CW: cwsing@connect.hku.hk-
dc.identifier.emailTan, KCB: kcbtan@hkucc.hku.hk-
dc.identifier.emailWong, ICK: wongick@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.emailCheung, CL: lung1212@hku.hk-
dc.identifier.authorityTan, KCB=rp00402-
dc.identifier.authorityWong, ICK=rp01480-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.authorityCheung, CL=rp01749-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1093/cid/ciaa992-
dc.identifier.pmid32671407-
dc.identifier.pmcidPMC7454482-
dc.identifier.hkuros313751-
dc.identifier.volumeEpub 2020-07-15-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats